BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fuggle NR, Cooper C, Harvey NC, Al-Daghri N, Brandi ML, Bruyere O, Cano A, Dennison EM, Diez-Perez A, Kaufman JM, Palacios S, Prieto-Alhambra D, Rozenberg S, Thomas T, Tremollieres F, Rizzoli R, Kanis JA, Reginster JY. Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs. Drugs 2020;80:1537-52. [PMID: 32725307 DOI: 10.1007/s40265-020-01364-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Delli Poggi C, Fusaro M, Mereu MC, Brandi ML, Cianferotti L. Cardiovascular Safety and Effectiveness of Bisphosphonates: From Intervention Trials to Real-Life Data. Nutrients 2022;14:2369. [PMID: 35745099 DOI: 10.3390/nu14122369] [Reference Citation Analysis]
2 Ma M, Fan AY, Liu Z, Yang LQ, Huang JM, Pang ZY, Yin F. Baohuoside I Inhibits Osteoclastogenesis and Protects Against Ovariectomy-Induced Bone Loss. Front Pharmacol 2022;13:874952. [PMID: 35571086 DOI: 10.3389/fphar.2022.874952] [Reference Citation Analysis]
3 Curtis EM, Reginster JY, Al-Daghri N, Biver E, Brandi ML, Cavalier E, Hadji P, Halbout P, Harvey NC, Hiligsmann M, Javaid MK, Kanis JA, Kaufman JM, Lamy O, Matijevic R, Perez AD, Radermecker RP, Rosa MM, Thomas T, Thomasius F, Vlaskovska M, Rizzoli R, Cooper C. Management of patients at very high risk of osteoporotic fractures through sequential treatments. Aging Clin Exp Res 2022;34:695-714. [PMID: 35332506 DOI: 10.1007/s40520-022-02100-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
4 Tominaga A, Wada K, Okazaki K, Nishi H, Terayama Y, Kato Y. Response to Letter. "Romosozumab and cardiovascular safety- should we learn lessons from Pioglitazone?.". Osteoporos Int 2022. [PMID: 35181822 DOI: 10.1007/s00198-022-06300-6] [Reference Citation Analysis]
5 Yang T, Lee SY, Park KC, Park SH, Chung J, Lee S. The Effects of Selenium on Bone Health: From Element to Therapeutics. Molecules 2022;27:392. [PMID: 35056706 DOI: 10.3390/molecules27020392] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
6 Bonaccorsi G, Rizzati M, Salani L, Giganti M. Postmenopausal osteoporosis: risk evaluation and treatment options. Minerva Obstet Gynecol 2021;73:714-29. [PMID: 34905877 DOI: 10.23736/S2724-606X.21.04896-X] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Li SS, He SH, Xie PY, Li W, Zhang XX, Li TF, Li DF. Recent Progresses in the Treatment of Osteoporosis. Front Pharmacol 2021;12:717065. [PMID: 34366868 DOI: 10.3389/fphar.2021.717065] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Rodríguez AJ, Abrahamsen B. Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies. JBMR Plus 2021;5:e10522. [PMID: 34258509 DOI: 10.1002/jbm4.10522] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Kaufman JM. Management of osteoporosis in older men. Aging Clin Exp Res 2021;33:1439-52. [PMID: 33821467 DOI: 10.1007/s40520-021-01845-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
10 Langer RD. The role of medications in successful aging. Climacteric 2021;24:505-12. [PMID: 33977831 DOI: 10.1080/13697137.2021.1911991] [Reference Citation Analysis]
11 Hassan N, Gregson CL, Tobias JH. Anabolic treatments for osteoporosis in postmenopausal women. Fac Rev 2021;10:44. [PMID: 34131654 DOI: 10.12703/r/10-44] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Jakob F. [Osteoporosis-Update 2021]. Dtsch Med Wochenschr 2021;146:437-40. [PMID: 33780987 DOI: 10.1055/a-1213-2245] [Reference Citation Analysis]
13 Obermayer-Pietsch B, Fössl I, Dimai HP. [Long-term treatment concepts for osteoporosis]. Internist (Berl) 2021;62:474-85. [PMID: 33710362 DOI: 10.1007/s00108-021-00993-3] [Reference Citation Analysis]
14 Lombardi F, Paoletti L, Carrieri B, Dell'Aquila G, Fedecostante M, Di Muzio M, Corsonello A, Lattanzio F, Cherubini A. Underprescription of medications in older adults: causes, consequences and solutions-a narrative review. Eur Geriatr Med 2021;12:453-62. [PMID: 33709336 DOI: 10.1007/s41999-021-00471-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Fuggle NR, Curtis B, Clynes M, Zhang J, Ward K, Javaid MK, Harvey NC, Dennison E, Cooper C. The treatment gap: The missed opportunities for osteoporosis therapy. Bone 2021;144:115833. [PMID: 33359889 DOI: 10.1016/j.bone.2020.115833] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
16 Cannata-Andía JB, Martín-Carro B, Martín-Vírgala J, Rodríguez-Carrio J, Bande-Fernández JJ, Alonso-Montes C, Carrillo-López N. Chronic Kidney Disease-Mineral and Bone Disorders: Pathogenesis and Management. Calcif Tissue Int 2021;108:410-22. [PMID: 33190187 DOI: 10.1007/s00223-020-00777-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]